Fluoroquinolones Flashcards

1
Q

fluoroquinolones are derivates of

A

nalidixic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

when fluoroquinolones were developed their main benefits were

A

Broad spectrum of activity

Improved PK properties – excellent oral bioavailability, tissue penetration, long half-lives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

fluoroquinolones mechanism of action

A

Inhibit DNA synthesis by inhibiting bacterial topoisomerases necessary for DNA synthesis

FQs display rapid, concentration-dependent bactericidal activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

primary target of fluoroquinolones in gram (-) bacteria

A

DNA gyrase (topoisomerase II) – removes excess positive supercoiling in the DNA helix

  • FQs form stable complex with DNA and DNA gyrase, which blocks DNA replication
  • Primary target in gram-negative bacteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

primary target of fluoroquinolones in gram (+) bacteria

A

Topoisomerase IV – essential for separation of interlinked daughter DNA molecules

  • FQs interfere with separation of daughter cells
  • Primary target for many gram-positive bacteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanisms of Resistance of fluoroquinolones

A

• Altered target sites – chromosomal mutations in genes that code for DNA gyrase or topoisomerase IV lead to decreased binding affinity
-Most important and most common
• Expression of active efflux – transfers FQs out of cell
• Altered cell wall permeability – decreased porin expression
• Plasmid mediated resistance
• Cross-resistance occurs between FQs (if resistant to one it will be resistant to them all)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The Available FQs

A

older:
Ciprofloxacin (Cipro®) – PO, IV

newer:
Levofloxacin (Levaquin®) – PO, IV
Moxifloxacin (Avelox®) – PO, IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which FQs have the best gram positive aerobe activity

A

Moxifloxacin and levofloxacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

target organism for newer FQs

A

Streptococcus pneumoniae (including PRSP)*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

which FQs have activity against Pseudomonas?

A

ciprofloxacin and levofloxacin with best activity but significant resistance has evolved (originally was the target organism)

NOT moxi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which FQs have the best activity against Enterbacteriaceae and H. influenzae

A

cipro and levo (best gram - aerobe activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

which FQ is best for anaerobes

A

Moxifloxacin (but more and more resistance is developing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which FQs have the best activity against atypically bacteria such as

Legionella pneumophila – DOC*
Chlamydophila and Chlamydia spp.
Mycoplasma spp.
Ureaplasma urealyticum

A

All have good activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

FQ absorption

A

very good bioavailability when given orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

FQ distribution

A

Extensive tissue distribution – lung; skin/soft tissue and bone; urinary tract and prostate (cipro, levo)

Moxi has good CSF penetration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

FQ elimination

A

Renally eliminated: levofloxacin (90%), ciprofloxacin (60%), gemifloxacin (36%)
Dosage adjustment required in the presence of renal insufficiency

Hepatically eliminated: moxifloxacin (80%)

17
Q

Fluoroquinolones most common clinical use

A

respiratory tract infections

Upper Respiratory Tract Infections
Sinusitis, bronchitis– levo, moxi, gemi, cipro

Lower Respiratory Tract Infections
• Community-acquired pneumonia - levo, moxi, gemi (Not cipro due to poor gram + coverage)
• Nosocomial (hospital acquired) pneumonia – anti-pseudomonal FQ’s: cipro (in combination with Gram + agent) & levo
• Exacerbations in cystic fibrosis - cipro

18
Q

clinical uses for FQs

A
  • Respiratory tract infections
  • Urinary tract infections pyelonephritis, prostatitis – cipro, levo
  • Other: bone, intraabdominal (with metronidazole), STDs, TB (levo, moxi)
19
Q

Fluoroquinolones
 Adverse Effects

A

MANY - At least 7 FQs have been removed from the market due to adverse effects

Most common are GI and CNS
Prolongation on QTc interval
Tendonitis, tendon rupture
Hepatotoxicity, photosensitivity, hypersensitivity, rash, articular damage

20
Q

cardiac adverse effects for FQs

A
  • Prolongation of QTc interval – may lead to Torsades
  • Use with caution in patients with hypokalemia, preexisting QT prolongation, concomitant antiarrhythmics
  • Use caution in combination with other drugs that prolong the QT (effects can be additive)

get a baseline Ekg before starting

21
Q

which patient populations are FQs contraindicated for

A

contraindication in pediatric patients and pregnant or breastfeeding women due to the articular cartilage damage

22
Q

important drug interactions with FQs

A

• Divalent and trivalent cations – ALL PO FQs
Zinc, Iron, Calcium, Aluminum, Magnesium
Antacids, sucralfate, didanosine, enteral feedings, calcium-rich foods (orange juice)
Impair absorption of orally-administered FQs – may lead to CLINICAL FAILURE
Administer doses 2 to 4 hours apart; administer the FQ first
• Warfarin – idiosyncratic, all FQs
• Theophylline and Cyclosporine - cipro
Inhibition of metabolism → ↑ levels, ↑ toxicity

23
Q

best FQs for community acquired pneumonia

A

levo, moxi, gemi

24
Q

best FQs for healthcare associate pneumonia

A

cipro (w/ another antibiotic for gram + coverage), levo

HCAP needs to cover pseudomas

25
Q

which FQs are good for Sinusitis, bronchitis

A

all

26
Q

which FQs are good for UTI, prostatitis

A

cipro, levo

27
Q

what is Metronidazole active against

A

protozoa and anaerobes

28
Q

what is metronidazones mechanism of action

A

given as a prodrug that ultimatly becomes activated and inhibits DNA synthesis of the bacteria

Metronidazole displays concentration-dependent bactericidal activity

29
Q

mechanisms of resistance for metronixazone

A

both are fairly uncommon

  1. Altered growth requirements – organisms grows in higher local oxygen concentrations causing decreased activation of metronidazole
  2. Altered ferredoxin levels – reduced transcription of the ferredoxin gene; less activation of metronidazole
30
Q

target organisms for metronidazones

A

bacteroides ssp. and clostridium spp

31
Q

metronidazone absorption

A

available IV and PO

Rapidly and completely absorbed (F > 90%); food with minimal effect on absorption

32
Q

metronidazone distribution

A

Good serum concentrations with PO or IV

Well absorbed into body tissues and fluids; **DOES penetrate the CSF

33
Q

metronidazone elimination

A

Metronidazole is primarily metabolized by the liver (metabolites excreted in urine); 6 to 15% excreted in the feces; half-life is 6 to 8 hours

Metronidazole is removed during hemodialysis

34
Q

clinical uses of metronidazone

A
Anaerobic Infections (including in the CNS)
Intraabdominal, pelvic, skin/soft tissue, diabetic foot and decubitus ulcer infections; brain abscess

Pseudomembranous colitis due to C. difficile
Metronidazole is the drug of Choice for MILD to MODERATE c.dif disease
PO or IV

Other
Bacterial vaginosis, Trichomonas, Amebiasis, H. pylori, Rosacea, Gingivitis

35
Q

adverse reactions to metronidazone

A

• Gastrointestinal- Most common ADR
Nausea, vomiting, stomatitis, metallic taste
• CNS – most serious
Peripheral neuropathy, seizures, encephalopathy
Use with caution in patients with preexisting CNS disorders
Requires discontinuation of metronidazole
• Mutagenicity, carcinogenicity
Avoid during pregnancy and breastfeeding

36
Q

metronidazone drug interactions

A

warfarin- ↑ Anticoagulant effect

alcohol - sever nausea and flushing (Disulfiram reaction)